Immupharma Plc announces licence agreement

November 28, 2019 06:45 AM EST | By Team Kalkine Media

Google News:

Recent News

Sage Potash Announces Director Resignation and Grant of Stock Options

Primary Hydrogen Announces LOI with Respect to Arthur Lake Property

Digital Silk Examines Key Healthcare Website Trends in California to S...

"How to Sell My Business at Peak Value" - IRAEmpire Publishes Guide Fo...

Avion Pharmaceuticals LLC and the company will jointly develop Lupuzor for marketing in US, Europe and other locations
Avion will market Lupuzor exclusively for the US
The company retains all the rights to market Lupuzor outside of the US
Avion will fund estimated costs of Phase III trial up to $25 million
On 28 November 2019, IMM shares were trading at GBX 16.70 at GMT 10:09 AM, up 9.65 points or 136.88% from the previous dayâs closing price level

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.